Broken String Biosciences Launches Catalyst Program to Shorten Gene Editing Therapy Development by Months

Contributed by: Business Wire

Tags

Health
Health Technology
Genetics
Research
Science
Pharmaceutical
Biotechnology
Broken String Biosciences

More Like This

Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization

Broken String Biosciences Renews Commitment to NIST Genome Editing Consortium, Bolstering Efforts to Standardize Gene Editing Safety

Business Wire logo

Parse Biosciences and Codebreaker Labs Partner to Apply Whole Transcriptome Single Cell Profiling and Causal Genomics at Scale

High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease

Business Wire logo

Cassidy Bio Launches with the Goal to Develop Safer, More Scalable Gene Editing Therapies

PR Newswire associated0

High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient

Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations

PR Newswire associated0

The World's First Clinical Base Edting Therapy for Hemoglobinopathy